Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionminus-end-directed microtubule motor activity

DNAH1 DNAH5 DNAH6

9.99e-05181023GO:0008569
GeneOntologyCellularComponentpiP-body

PIWIL4 MAEL

2.38e-0451032GO:0071547
GeneOntologyCellularComponentaxonemal dynein complex

DNAH1 DNAH5 DNAH6

2.47e-04251033GO:0005858
DomainTPR-like_helical_dom

POLR1A NASP COPS3 PEX5L TOMM70 CLTC WDR35 TANC1 CLUH

4.84e-062331019IPR011990
DomainDynein_heavy_chain_D4_dom

DNAH1 DNAH5 DNAH6

5.35e-05141013IPR024317
DomainDynein_HC_stalk

DNAH1 DNAH5 DNAH6

5.35e-05141013IPR024743
DomainDynein_heavy_dom-2

DNAH1 DNAH5 DNAH6

5.35e-05141013IPR013602
DomainDHC_N2

DNAH1 DNAH5 DNAH6

5.35e-05141013PF08393
DomainATPase_dyneun-rel_AAA

DNAH1 DNAH5 DNAH6

5.35e-05141013IPR011704
DomainMT

DNAH1 DNAH5 DNAH6

5.35e-05141013PF12777
DomainAAA_8

DNAH1 DNAH5 DNAH6

5.35e-05141013PF12780
DomainAAA_5

DNAH1 DNAH5 DNAH6

5.35e-05141013PF07728
DomainDHC_fam

DNAH1 DNAH5 DNAH6

6.66e-05151013IPR026983
DomainDynein_heavy

DNAH1 DNAH5 DNAH6

6.66e-05151013PF03028
DomainDynein_heavy_dom

DNAH1 DNAH5 DNAH6

6.66e-05151013IPR004273
DomainRNA_pol_Rpb1_2

POLR1A POLR2A

8.66e-0531012PF00623
DomainRNA_pol_asu

POLR1A POLR2A

8.66e-0531012IPR000722
DomainRNA_pol_N

POLR1A POLR2A

8.66e-0531012IPR006592
DomainRNA_pol_Rpb1_1

POLR1A POLR2A

8.66e-0531012PF04997
DomainRNA_pol_Rpb1_5

POLR1A POLR2A

8.66e-0531012PF04998
DomainRNA_pol_Rpb1_3

POLR1A POLR2A

8.66e-0531012PF04983
DomainRNA_pol_Rpb1_4

POLR1A POLR2A

8.66e-0531012PF05000
DomainRPOLA_N

POLR1A POLR2A

8.66e-0531012SM00663
DomainRNA_pol_Rpb1_4

POLR1A POLR2A

8.66e-0531012IPR007083
DomainRNA_pol_Rpb1_5

POLR1A POLR2A

8.66e-0531012IPR007081
DomainRNA_pol_Rpb1_1

POLR1A POLR2A

8.66e-0531012IPR007080
DomainRNA_pol_Rpb1_3

POLR1A POLR2A

8.66e-0531012IPR007066
DomainSTAT_TF_DNA-bd_sub

STAT2 STAT5A

5.97e-0471012IPR012345
DomainSTAT

STAT2 STAT5A

5.97e-0471012IPR001217
DomainSTAT_int

STAT2 STAT5A

5.97e-0471012SM00964
DomainSTAT_TF_DNA-bd

STAT2 STAT5A

5.97e-0471012IPR013801
DomainSTAT_bind

STAT2 STAT5A

5.97e-0471012PF02864
DomainSTAT_int

STAT2 STAT5A

5.97e-0471012PF02865
Domain-

STAT2 STAT5A

5.97e-04710121.10.532.10
DomainSTAT_alpha

STAT2 STAT5A

5.97e-0471012PF01017
Domain-

STAT2 STAT5A

5.97e-04710121.20.1050.20
DomainSTAT_TF_prot_interaction

STAT2 STAT5A

5.97e-0471012IPR013799
DomainSTAT_TF_coiled-coil

STAT2 STAT5A

5.97e-0471012IPR015988
Domain-

STAT2 STAT5A

5.97e-04710122.60.40.630
DomainPIWI

PIWIL4 AGO4

7.94e-0481012PS50822
DomainPiwi

PIWIL4 AGO4

7.94e-0481012SM00950
DomainSTAT_TF_alpha

STAT2 STAT5A

7.94e-0481012IPR013800
DomainPiwi

PIWIL4 AGO4

7.94e-0481012PF02171
DomainPiwi

PIWIL4 AGO4

7.94e-0481012IPR003165
Domain-

NASP PEX5L TOMM70 CLTC TANC1 CLUH

9.12e-0420710161.25.40.10
DomainPAZ

PIWIL4 AGO4

1.02e-0391012PS50821
DomainPAZ

PIWIL4 AGO4

1.02e-0391012SM00949
DomainPAZ

PIWIL4 AGO4

1.02e-0391012PF02170
DomainPAZ_dom

PIWIL4 AGO4

1.02e-0391012IPR003100
DomainAmino_oxidase

PYROXD2 IL4I1

1.27e-03101012IPR002937
DomainAmino_oxidase

PYROXD2 IL4I1

1.27e-03101012PF01593
DomainFrizzled

FZD5 FZD2

1.54e-03111012IPR000539
DomainFrizzled

FZD5 FZD2

1.54e-03111012PF01534
DomainFrizzled

FZD5 FZD2

1.54e-03111012SM01330
DomainTPR_REGION

NASP PEX5L TOMM70 TANC1 CLUH

2.03e-031651015PS50293
DomainTPR

NASP PEX5L TOMM70 TANC1 CLUH

2.03e-031651015PS50005
Domain-

POLD1 PIWIL4 AGO4

2.09e-034710133.30.420.10
Domainp53-like_TF_DNA-bd

STAT2 STAT5A IL17RB

2.96e-03531013IPR008967
DomainFrizzled/SFRP

FZD5 FZD2

3.31e-03161012IPR015526
DomainFRI

FZD5 FZD2

5.16e-03201012SM00063
DomainTPR

NASP PEX5L TOMM70 TANC1

5.29e-031291014SM00028
PathwayREACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD2_FZD5_AND_ROR2

FZD5 CLTC FZD2

2.95e-0512743MM15163
PathwayREACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD2_FZD5_AND_ROR2

FZD5 CLTC FZD2

3.82e-0513743M27415
PathwayKEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_LGR_RSPO

ZNRF3 FZD5 FZD2

1.27e-0419743M47833
PathwayBIOCARTA_LIS1_PATHWAY

RELN DNAH1 DNAH6

1.27e-0419743M22005
PathwayWP_WNT_SIGNALING_AND_PLURIPOTENCY

PPP2R3A FZD5 PRKCH FZD2 EP300

1.86e-04101745M39387
Pubmed

Systematic analysis of human protein complexes identifies chromosome segregation proteins.

SCFD2 TCN1 CENPF POLR2A DTL COPS3 GTF3C6 TASOR2 FBXO38 LLGL2 CEP78 BSG CLTC TLN2 ATL2 SLX4 CRBN XRCC6

8.09e-0911551031820360068
Pubmed

Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.

POLR1A CENPF POLD1 POLR2A NASP KRI1 COPS3 GRSF1 TOMM70 BSG CLTC TLN2 MYO18B ATL2 DNAH5 CLUH XRCC6

9.62e-0714251031730948266
Pubmed

FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.

DCHS2 POLR1A CENPF POLD1 POLR2A NASP AK9 COPS3 STAT5A BSG

2.34e-064971031036774506
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

DCHS2 RELN OXR1 NASP SRGAP2 TXNDC15 NDRG1 CLTC ZBTB5 ENPP5 TLN2 PJA1 EP300 SLX4 XRCC6

5.84e-0612851031535914814
Pubmed

A ubiquitin-binding domain in Cockayne syndrome B required for transcription-coupled nucleotide excision repair.

POLR1A POLD1 POLR2A

7.06e-0613103320541997
Pubmed

Expression of UDP Glucuronosyltransferases 2B15 and 2B17 is associated with methylation status in prostate cancer cells.

UGT2B15 UGT2B17

8.69e-062103232660355
Pubmed

The UDP glucuronosyltransferase gene superfamily: suggested nomenclature based on evolutionary divergence.

UGT2B15 UGT2B17

8.69e-06210321909870
Pubmed

Androgen glucuronidation: an unexpected target for androgen deprivation therapy, with prognosis and diagnostic implications.

UGT2B15 UGT2B17

8.69e-062103224121496
Pubmed

Structural basis for recognition of frizzled proteins by Clostridium difficile toxin B.

FZD5 FZD2

8.69e-062103229748286
Pubmed

Novel associations of UDP-glucuronosyltransferase 2B gene variants with prostate cancer risk in a multiethnic study.

UGT2B15 UGT2B17

8.69e-062103224267955
Pubmed

Differential expression of the androgen-conjugating UGT2B15 and UGT2B17 enzymes in prostate tumor cells during cancer progression.

UGT2B15 UGT2B17

8.69e-062103222170718
Pubmed

Localization of UDP glucuronosyltransferase gene(s) on mouse chromosome 5.

UGT2B15 UGT2B17

8.69e-06210323105095
Pubmed

UDP-glucuronosyltransferase 2B15 (UGT2B15) and UGT2B17 enzymes are major determinants of the androgen response in prostate cancer LNCaP cells.

UGT2B15 UGT2B17

8.69e-062103217848572
Pubmed

[From gene to disease; Dent's disease caused by abnormalities in the CLCN5 and OCRL1 genes].

OCRL CLCN5

8.69e-062103218019214
Pubmed

Dent Disease in Chinese Children and Findings from Heterozygous Mothers: Phenotypic Heterogeneity, Fetal Growth, and 10 Novel Mutations.

OCRL CLCN5

8.69e-062103227174143
Pubmed

Androgen and Estrogen Receptors in Breast Cancer Coregulate Human UDP-Glucuronosyltransferases 2B15 and 2B17.

UGT2B15 UGT2B17

8.69e-062103227496708
Pubmed

Dent Disease

OCRL CLCN5

8.69e-062103222876375
Pubmed

The uridine diphosphate glucuronosyltransferase 2B15 D85Y and 2B17 deletion polymorphisms predict the glucuronidation pattern of androgens and fat mass in men.

UGT2B15 UGT2B17

8.69e-062103217698910
Pubmed

Lowe syndrome protein OCRL1 interacts with clathrin and regulates protein trafficking between endosomes and the trans-Golgi network.

OCRL CLTC

8.69e-062103215917292
Pubmed

p300/CREB-binding protein enhances the prolactin-mediated transcriptional induction through direct interaction with the transactivation domain of Stat5, but does not participate in the Stat5-mediated suppression of the glucocorticoid response.

STAT5A EP300

8.69e-06210329773981
Pubmed

Japanese Dent disease has a wider clinical spectrum than Dent disease in Europe/USA: genetic and clinical studies of 86 unrelated patients with low-molecular-weight proteinuria.

OCRL CLCN5

8.69e-062103224081861
Pubmed

Mouse UDP glucuronosyltransferase. cDNA and complete amino acid sequence and regulation.

UGT2B15 UGT2B17

8.69e-06210323117546
Pubmed

Cajal-Retzius cells switch from expressing gamma-less to gamma-containing GABA receptors during corticogenesis.

GABRG2 RELN

8.69e-062103217074040
Pubmed

Phenotypic spectrum and antialbuminuric response to angiotensin converting enzyme inhibitor and angiotensin receptor blocker therapy in pediatric Dent disease.

OCRL CLCN5

8.69e-062103232495484
Pubmed

Comprehensive Characterization of Mouse UDP-Glucuronosyltransferase (Ugt) Belonging to the Ugt2b Subfamily: Identification of Ugt2b36 as the Predominant Isoform Involved in Morphine Glucuronidation.

UGT2B15 UGT2B17

8.69e-062103228228532
Pubmed

Clinical features and genetic analysis of 15 Chinese children with dent disease.

OCRL CLCN5

8.69e-062103238726999
Pubmed

Multicenter study of the clinical features and mutation gene spectrum of Chinese children with Dent disease.

OCRL CLCN5

8.69e-062103231674016
Pubmed

Cellular specific expression of the androgen-conjugating enzymes UGT2B15 and UGT2B17 in the human prostate epithelium.

UGT2B15 UGT2B17

8.69e-062103215666817
Pubmed

Identification of dynein heavy chain genes expressed in human and mouse testis: chromosomal localization of an axonemal dynein gene.

DNAH1 DNAH5 DNAH6

8.97e-061410339373155
Pubmed

STAT5A modulates CDYL2/SLC7A6 pathway to inhibit the proliferation and invasion of hepatocellular carcinoma by targeting to mTORC1.

STAT5A CDYL2

2.60e-053103235314791
Pubmed

Copy-number variations (CNVs) of the human sex steroid metabolizing genes UGT2B17 and UGT2B28 and their associations with a UGT2B15 functional polymorphism.

UGT2B15 UGT2B17

2.60e-053103219572376
Pubmed

OCRL deficiency impairs endolysosomal function in a humanized mouse model for Lowe syndrome and Dent disease.

OCRL CLCN5

2.60e-053103230590522
Pubmed

Epigenetic regulation of steroid inactivating UDP-glucuronosyltransferases by microRNAs in prostate cancer.

UGT2B15 UGT2B17

2.60e-053103226385605
Pubmed

IKZF1 expression is a prognostic marker in newly diagnosed standard-risk multiple myeloma treated with lenalidomide and intensive chemotherapy: a study of the German Myeloma Study Group (DSMM).

BSG CRBN

2.60e-053103228017969
Pubmed

A PH domain within OCRL bridges clathrin-mediated membrane trafficking to phosphoinositide metabolism.

OCRL CLTC

2.60e-053103219536138
Pubmed

DNAH6 and Its Interactions with PCD Genes in Heterotaxy and Primary Ciliary Dyskinesia.

DNAH5 DNAH6

2.60e-053103226918822
Pubmed

Distinct components of Janus kinase/signal transducer and activator of transcription signaling pathway mediate the regulation of systemic and tissue localized renin-angiotensin system.

STAT5A EP300

2.60e-053103214726487
Pubmed

Regulation of Human UGT2B15 and UGT2B17 by miR-376c in Prostate Cancer Cell Lines.

UGT2B15 UGT2B17

2.60e-053103226163549
Pubmed

Forkhead box protein A1 regulates UDP-glucuronosyltransferase 2B15 gene transcription in LNCaP prostate cancer cells.

UGT2B15 UGT2B17

2.60e-053103220736324
Pubmed

Genetic variations in UGT2B28, UGT2B17, UGT2B15 genes and the risk of prostate cancer: A case-control study.

UGT2B15 UGT2B17

2.60e-053103228882566
Pubmed

OCRL1 Deficiency Affects the Intracellular Traffic of ApoER2 and Impairs Reelin-Induced Responses.

RELN OCRL

2.60e-053103239062513
Pubmed

SNX4 in complex with clathrin and dynein: implications for endosome movement.

DNAH1 CLTC

2.60e-053103219529763
Pubmed

EP300 Selectively Controls the Enhancer Landscape of MYCN-Amplified Neuroblastoma.

EP300 CRBN

2.60e-053103234772733
Pubmed

The inositol polyphosphate 5-phosphatase Ocrl associates with endosomes that are partially coated with clathrin.

OCRL CLTC

2.60e-053103215353600
Pubmed

Contribution of Common Variants in GABRG2, RELN and NRG3 and Interaction Networks to the Risk of Hirschsprung Disease.

GABRG2 RELN

2.60e-053103227889765
Pubmed

Activators of the farnesoid X receptor negatively regulate androgen glucuronidation in human prostate cancer LNCAP cells.

UGT2B15 UGT2B17

2.60e-053103217988216
Pubmed

RECQ5 helicase promotes resolution of conflicts between replication and transcription in human cells.

POLR1A POLR2A

2.60e-053103227502483
Pubmed

Tissue distribution and relative gene expression of UDP-glucuronosyltransferases (2B7, 2B15, 2B17) in the human fetus.

UGT2B15 UGT2B17

2.60e-053103223223495
Pubmed

Androgen receptor mediates the expression of UDP-glucuronosyltransferase 2 B15 and B17 genes.

UGT2B15 UGT2B17

2.60e-053103218302198
Pubmed

The nuclear receptor Shp regulates morphine withdrawal syndrome via modulation of Ugt2b expression in mice.

UGT2B15 UGT2B17

2.60e-053103230689982
Pubmed

GABAA/benzodiazepine receptor gamma 2 subunit gene expression in developing normal and mutant mouse cerebellum.

GABRG2 RELN

5.19e-05410328395631
Pubmed

Murine leukemia retrovirus integration induces the formation of transcription factor complexes on palindromic sequences in the signal transducer and activator of transcription factor 5a gene during the development of pre-B lymphomagenesis.

STAT5A EP300

5.19e-054103221356387
Pubmed

Nitric oxide induces the progression of abdominal aortic aneurysms through the matrix metalloproteinase inducer EMMPRIN.

BSG MMP13

5.19e-054103219779140
Pubmed

Argonaute proteins: potential biomarkers for human colon cancer.

PIWIL4 AGO4

5.19e-054103220146808
Pubmed

Mutations in dynein genes in patients affected by isolated non-syndromic asthenozoospermia.

DNAH1 DNAH5

5.19e-054103218492703
Pubmed

PCNA-Dependent Cleavage and Degradation of SDE2 Regulates Response to Replication Stress.

DTL IL17RB

5.19e-054103227906959
Pubmed

Synergism between p68 RNA helicase and the transcriptional coactivators CBP and p300.

POLR2A EP300

5.19e-054103212527917
Pubmed

Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors.

ZNRF3 FZD5

5.19e-054103222895187
Pubmed

Mutational analysis of CLC-5, cofilin and CLC-4 in patients with Dent's disease.

OCRL CLCN5

5.19e-054103219546591
Pubmed

Calcitrol (1alpha,25-dihydroxyvitamin D3) inhibits androgen glucuronidation in prostate cancer cells.

UGT2B15 UGT2B17

5.19e-054103218281521
Pubmed

TEX15 is an essential executor of MIWI2-directed transposon DNA methylation and silencing.

PIWIL4 TASOR2

5.19e-054103232719317
Pubmed

Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients.

UGT2B15 UGT2B17

5.19e-054103226176234
Pubmed

Human T-cell leukemia virus type 1 Tax modulates interferon-alpha signal transduction through competitive usage of the coactivator CBP/p300.

STAT2 EP300

5.19e-054103218678383
Pubmed

The Maternal Microbiome Programs the m6A Epitranscriptome of the Mouse Fetal Brain and Intestine.

CABP1 GABRG2 FZD5

5.53e-0525103335874829
Pubmed

Deletion of the T-box transcription factor gene, Tbx1, in mice induces differential expression of genes associated with cleft palate in humans.

GABRG2 NDRG1 MMP13

6.24e-0526103330121012
Pubmed

Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis.

EP300 XRCC6

8.64e-055103215023334
Pubmed

Stat protein transactivation domains recruit p300/CBP through widely divergent sequences.

STAT2 EP300

8.64e-055103210464260
Pubmed

The post-translational modifications of proliferating cell nuclear antigen: acetylation, not phosphorylation, plays an important role in the regulation of its function.

POLD1 EP300

8.64e-055103214988403
Pubmed

The Argonaute family: tentacles that reach into RNAi, developmental control, stem cell maintenance, and tumorigenesis.

PIWIL4 AGO4

8.64e-055103212414724
Pubmed

Primary Ciliary Dyskinesia Associated Disease-Causing Variants in CCDC39 and CCDC40 Cause Axonemal Absence of Inner Dynein Arm Heavy Chains DNAH1, DNAH6, and DNAH7.

DNAH1 DNAH6

8.64e-055103239056782
Pubmed

CBP and p300 acetylate PCNA to link its degradation with nucleotide excision repair synthesis.

POLD1 EP300

8.64e-055103224939902
Pubmed

RhoA/ROCK activation by growth hormone abrogates p300/histone deacetylase 6 repression of Stat5-mediated transcription.

STAT5A EP300

8.64e-055103215102857
Pubmed

A DNA-binding domain in the C-terminal region of Cdt2 enhances the DNA synthesis-coupled CRL4Cdt2 ubiquitin ligase activity for Cdt1.

DTL IL17RB

8.64e-055103230649446
Pubmed

Molecular architecture and assembly of the DDB1-CUL4A ubiquitin ligase machinery.

DTL COPS3 CRBN

1.18e-0432103316964240
Pubmed

Impaired plasma membrane localization of ubiquitin ligase complex underlies 3-M syndrome development.

POLR1A POLD1 GRSF1 TASOR2 DNAH1 FER1L4 UGT2B17 MYO18B

1.18e-04496103831343991
Pubmed

The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.

CENPF POLR2A NASP KRI1 CLTC TANC1

1.18e-04256103633397691
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

POLR1A SRGAP2 TASOR2 DNAH1 FOXP4 PPP2R3A NDRG1 SHANK2 RAB3IP CDYL2 ENPP5 TANC1 QSER1 EP300

1.28e-0414891031428611215
Pubmed

Cell fate decisions by c-Myc depend on ZBTB5 and p53.

ZBTB5 EP300

1.29e-046103233051058
Pubmed

The immunoglobulin-superfamily molecule basigin is a binding protein for oligomannosidic carbohydrates: an anti-idiotypic approach.

BSG ATP1B2

1.29e-046103212558975
Pubmed

Actinomycin D induces histone gamma-H2AX foci and complex formation of gamma-H2AX with Ku70 and nuclear DNA helicase II.

POLR2A XRCC6

1.29e-046103215613478
Pubmed

Association of STATs with relatives and friends.

STAT2 STAT5A

1.29e-046103210675904
Pubmed

Steroidogenic enzymes and stem cell markers are upregulated during androgen deprivation in prostate cancer.

UGT2B15 UGT2B17

1.29e-046103221365123
Pubmed

An inherently bifunctional subset of Foxp3+ T helper cells is controlled by the transcription factor eos.

IKZF4 CD40LG

1.29e-046103223684987
Pubmed

Expression of extracellular matrix metalloproteinase inducer and matrix metalloproteinases during mouse embryonic development.

BSG MMP13

1.81e-047103217307908
Pubmed

Cyclin-dependent kinase-9 is a component of the p300/GATA4 complex required for phenylephrine-induced hypertrophy in cardiomyocytes.

POLR2A EP300

1.81e-047103220081228
Pubmed

Isolation of several human axonemal dynein heavy chain genes: genomic structure of the catalytic site, phylogenetic analysis and chromosomal assignment.

DNAH1 DNAH5

1.81e-04710329256245
Pubmed

The CBP/p300 TAZ1 domain in its native state is not a binding partner of MDM2.

STAT2 EP300

1.81e-047103215154850
Pubmed

Weak activity of UDP-glucuronosyltransferase toward Bisphenol analogs in mouse perinatal development.

UGT2B15 UGT2B17

1.81e-047103226074487
Pubmed

Mouse GTSF1 is an essential factor for secondary piRNA biogenesis.

PIWIL4 MAEL

1.81e-047103229437694
Pubmed

STAT transcription factors in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention.

STAT2 STAT5A

1.81e-047103223797472
Pubmed

Signaling through the JAK/STAT pathway, recent advances and future challenges.

STAT2 STAT5A

1.81e-047103212039028
Pubmed

Expression and activation of STAT proteins during mouse retina development.

STAT2 STAT5A

1.81e-047103212634107
Pubmed

Immunomodulatory drugs disrupt the cereblon-CD147-MCT1 axis to exert antitumor activity and teratogenicity.

BSG CRBN

1.81e-047103227294876
Pubmed

STAT heterodimers in immunity: A mixed message or a unique signal?

STAT2 STAT5A

1.81e-047103224058793
Pubmed

The corepressor activity of Alien is controlled by CREB-binding protein/p300.

TRMO EP300

1.81e-047103223441852
Pubmed

Physiological significance of STAT proteins: investigations through gene disruption in vivo.

STAT2 STAT5A

1.81e-047103210526573
Pubmed

Analysis of the myosin-II-responsive focal adhesion proteome reveals a role for β-Pix in negative regulation of focal adhesion maturation.

BSG SCARB2 CLTC TLN2 FZD2 PALLD

2.11e-04285103621423176
Pubmed

CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1.

GRSF1 FOXP4 CLTC PALLD CRBN

2.15e-04182103531067453
Pubmed

Acetylation-dependent signal transduction for type I interferon receptor.

STAT2 EP300

2.40e-048103217923090
Pubmed

Tdrkh is essential for spermatogenesis and participates in primary piRNA biogenesis in the germline.

PIWIL4 MAEL

2.40e-048103223714778
Cytoband4q13

GRSF1 UGT2B15 UGT2B17

4.89e-061510334q13
GeneFamilyDyneins, axonemal

DNAH1 DNAH5 DNAH6

3.79e-0517713536
GeneFamilyArgonaute/PIWI family

PIWIL4 AGO4

4.19e-048712408
GeneFamilyG protein-coupled receptors, Class F frizzled

FZD5 FZD2

8.17e-0411712286
GeneFamilyTetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome

NASP PEX5L TOMM70 TANC1

1.09e-03115714769
GeneFamilyCadherin related

DCHS2 CDHR1

1.99e-031771224
CoexpressionPEREZ_TP63_TARGETS

PLIN4 FOXP4 ZNF600 NDRG1 ZNRF3 PTX3 RAB3IP CDYL2 PRKCH IL17RB

1.45e-0635610310M10761
CoexpressionGSE22140_GERMFREE_VS_SPF_ARTHRITIC_MOUSE_CD4_TCELL_DN

POLR2A SRGAP2 GRSF1 STAT2 STAT5A NDRG1 FZD2

1.40e-051991037M7645
CoexpressionGSE44649_WT_VS_MIR155_KO_ACTIVATED_CD8_TCELL_UP

STAT2 IKZF4 FOXP4 NDRG1 XPO6 FZD5 IL4I1

1.40e-051991037M9782
CoexpressionSENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP

DOCK4 CENPF DTL PIWIL4 PM20D2 ZNRF3 QSER1 ATL2

2.80e-053051038M19875
CoexpressionFOSTER_TOLERANT_MACROPHAGE_DN

STAT5A TASOR2 FOXP4 ZNRF3 PTX3 FZD5 TANC1 MMP13 IL4I1

4.10e-054181039M12676
CoexpressionPYEON_HPV_POSITIVE_TUMORS_UP

CENPF DTL NASP CEP78 IL17RB

4.99e-051011035M7738
CoexpressionFOSTER_TOLERANT_MACROPHAGE_DN

STAT5A TASOR2 FOXP4 ZNRF3 PTX3 FZD5 TANC1 MMP13 IL4I1

5.57e-054351039MM1221
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

OXR1 PPP2R3A LLGL2 SHANK2 CLCN5 ZNRF3 RAB3IP

3.47e-07194103793c68c31e39fa44c1d05d7d4997f4f086da4e738
ToppCellCOVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type

DCHS2 RELN OXR1 PPP2R3A SHANK2 ZNRF3

3.67e-061781036544379f5a6145429762258d426b876bb36c112f5
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RELN GRIK3 FREM1 DNAH1 TLN2 DNAH5

4.44e-0618410362cbed6462fea2622871bb7e49b0df3d984239281
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RELN GRIK3 FREM1 DNAH1 TLN2 DNAH5

4.44e-061841036ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RELN GRIK3 FREM1 DNAH1 TLN2 DNAH5

4.44e-0618410362b19a8c5f823e00812908b23e66bb4e563278aff
ToppCellSomatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

RELN GRIK3 RAB3IP CNTNAP2 TANC1 ATP1B2

5.83e-061931036d1445b8bf2bab36e1a326ddb2a528151db016c7d
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

RELN GRIK3 FREM1 RAB3IP TANC1 ATP1B2

5.83e-0619310362c15186d15545804cc262da9137ab825609d4b2c
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

RELN GRIK3 RAB3IP CNTNAP2 TANC1 ATP1B2

5.83e-061931036010717ca052b6c8a525a43aaeffddea0d1113e63
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

OXR1 PPP2R3A LLGL2 SHANK2 CLCN5 ZNRF3

5.83e-06193103682e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

OXR1 PPP2R3A LLGL2 SHANK2 CLCN5 ZNRF3

5.83e-0619310363866667dd221612589ae50f5c52f73a183a49ce6
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

OXR1 PPP2R3A LLGL2 SHANK2 CLCN5 ZNRF3

6.01e-0619410365eaaa81f4b2535f983c424aaef00077089526a5c
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

OXR1 PPP2R3A LLGL2 SHANK2 CLCN5 ZNRF3

6.19e-0619510366477e6e7be5bd8eb99119a12ae16334ccddecd43
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

OXR1 PPP2R3A LLGL2 SHANK2 CLCN5 ZNRF3

6.37e-0619610366ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

OXR1 PPP2R3A LLGL2 SHANK2 CLCN5 ZNRF3

6.37e-061961036eea66711a16134f86e6c533a5a837ff2e0d7ca7f
ToppCellTracheal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

CENPF PPM1E AK9 DNAH1 DNAH5 DNAH6

6.56e-0619710366e4a411ef823ce9e16f420e185e21fa19d13af34
ToppCellNeuronal-Inhibitory-iB-iB_4(SST)-HPGD-|Neuronal / cells hierarchy compared to all cells using T-Statistic

GRIK3 FREM1 RAB3IP CNTNAP2 TANC1 ATP1B2

7.15e-0620010361ec2f322f936d2501330c53bb7c9390216c50cd1
ToppCellNeuronal-Inhibitory-iB-iB_4(SST)-HPGD--L3-6|Neuronal / cells hierarchy compared to all cells using T-Statistic

GRIK3 FREM1 RAB3IP CNTNAP2 TANC1 ATP1B2

7.15e-062001036e250b2e45ef869f81cc40cc41f53d1e54e7848aa
ToppCellNeuronal-Inhibitory-iB-iB_4(SST)-HPGD|Neuronal / cells hierarchy compared to all cells using T-Statistic

GRIK3 FREM1 RAB3IP CNTNAP2 TANC1 ATP1B2

7.15e-062001036dea96adbd9a77fe50ff397d4bdeb4dc8f50de3b7
ToppCellNS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

CENPF DTL AK9 CEP78 DNAH6

3.23e-051571035410c9d74a2085179cfb39853cb6d330fa98c9c1b
ToppCellfacs-Lung-ENDOMUCIN-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CPN2 IKZF4 STAT5A RAB3IP CD40LG

3.86e-0516310354af92b211d12c5b88b65bb746242cd702b545bd0
ToppCellfacs-Lung-ENDOMUCIN-18m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CPN2 IKZF4 STAT5A RAB3IP CD40LG

3.86e-051631035d24774e0aa612322c22fdb3b314aef275fa01d68
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

DOCK4 RELN DTL NASP PRKCH

4.09e-0516510356a621b300442c52adfc15b61d3a6d3a3cb00099f
ToppCellFetal_29-31_weeks-Endothelial-endothelial_cell_of_bronchial_vessel-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

PLIN4 RELN KRI1 FZD5 DNAH6

4.21e-051661035a697460dfe72e08fbf7d8e734a16b7dd2c6d86f9
ToppCellfacs-Brain_Non-Myeloid-Cerebellum_-18m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NAT1 TCN1 PYROXD2 ATP1B2 FZD2

4.33e-0516710352184c2760b6142e62124a2454a552723e20d4f61
ToppCellVE-Treg-exh_CD4|VE / Condition, Cell_class and T cell subcluster

RC3H2 PDE8A OCRL TOMM70 PJA1

4.33e-0516710351036ac1ef9440612500137af9d1929672b077e4d
ToppCellfacs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

POLR2A DNAH1 CNTNAP2 DNAH5 DNAH6

4.58e-05169103512bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCellFetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

NAT1 PPM1E LGSN DNAH5 DNAH6

5.86e-051781035de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6
ToppCellfacs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RELN CENPF PPM1E DNAH1 CNTNAP2

6.02e-051791035479116ac65488c60104a053530830763ec1f95b2
ToppCellfacs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RELN CENPF PPM1E DNAH1 CNTNAP2

6.02e-0517910351dfc0cb8b369aef35c59f3d4c52603dc9f3728c1
ToppCellfacs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RELN CENPF PPM1E DNAH1 CNTNAP2

6.02e-05179103569a1b3b05c921de6343ffe6ad998aa2b804312a7
ToppCellfacs-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

RELN CDHR1 NDRG1 PTX3 GSDMA

6.34e-051811035b0fff0defba9aea6fba36e378b05a59986e2573a
ToppCellfacs-Spleen-nan-3m-Lymphocytic-Cd3e_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ZNRF3 RAB3IP CD40LG PRKCH TANC1

6.34e-051811035be7c7db6b99603759593e6f79cdcaa4bbf234cb7
ToppCellfacs-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

RELN CDHR1 NDRG1 PTX3 GSDMA

6.34e-051811035cc77ac0e223e012767222e45c5dcadc246d1aa7c
ToppCellfacs-Lung-18m-Endothelial-lymphatic_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

RELN CDHR1 NDRG1 PTX3 GSDMA

6.34e-051811035ecd52f33841f4e9d946a4edad0d58da9b0cc5ffa
ToppCellCOVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type

OXR1 PPP2R3A SHANK2 RAB3IP IL17RB

6.68e-0518310356878d14026c3df6aa12e45dfad94b32fa9d9b0b7
ToppCell3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DCHS2 CENPF SRGAP2 AGO4 FZD5

6.68e-05183103591079a11685dd466bd27a0cf5afbf3734c08a05e
ToppCell390C-Lymphocytic-CD4_T-cell-Treg_cell_3|390C / Donor, Lineage, Cell class and subclass (all cells)

POLD1 PYROXD2 IKZF4 NDRG1 WDR35

6.68e-051831035228092290dbb08785c4eda224e3ad03e99e10fab
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

LLGL2 NDRG1 SHANK2 ATL2 DNAH5

7.22e-0518610352ea5ff14861e5f91d0e6a5767c403a24045d715c
ToppCellCOVID-19-kidney-Mito-rich_Distal|kidney / Disease (COVID-19 only), tissue and cell type

OXR1 PPM1E PPP2R3A CLCN5 DNAH5

7.40e-0518710352ce8038d9d1302e850c1bb536e755598f77ba4b9
ToppCell390C-Lymphocytic-CD4_T-cell-Treg_cell_3|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)

POLD1 PYROXD2 IKZF4 NDRG1 WDR35

7.40e-0518710351eed2c1a05e80a7c8f639437c117afe0c18dfb0c
ToppCellCOVID-19-kidney|COVID-19 / Disease (COVID-19 only), tissue and cell type

OXR1 PPP2R3A NDRG1 SHANK2 IL17RB

7.40e-051871035d23aae9419d460b78b1d4092d7acd9108a47cfbe
ToppCelldroplet-Spleen-nan-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CENPF DTL PM20D2 GSDMA ATP1B2

7.59e-0518810351a3f95b4fd7611c634666761ddf21f1e58e56af8
ToppCellfacs-Mammary_Gland-Mammary_Gland-21m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

POLR2A GRIK3 IKZF4 FOXP4 PALLD

7.78e-051891035965e0e388251e7318f8b463816dc96ccb4658677
ToppCell10x5'-bone_marrow-Lymphocytic_Invariant-Inducer-like|bone_marrow / Manually curated celltypes from each tissue

PDE8A CD40LG IL4I1 IL17RB CCDC107

7.78e-051891035ac2995e599f3d1813218479dc515b1d612c0ef8b
ToppCellPBMC-Severe-cDC_12|Severe / Compartment, Disease Groups and Clusters

CENPF POLD1 DTL NASP CEP78

7.98e-05190103584ee185939bdefb10705b621a70da27701eadcee
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

DOCK4 LMTK2 LLGL2 SHANK2 PALLD

7.98e-05190103530b50d183d7649146eb1e79b47ba897355f1998a
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

CABP1 OXR1 PPM1E SHANK2 CLCN5

7.98e-051901035cc17ab84a9328124f146951c06be3eff9650d9fd
ToppCelldroplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PLIN4 CABP1 PPM1E ATP1B2 PALLD

8.18e-0519110358e8beb8e8a3b33cac83d3f7ce915a71e3654fdab
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CABP1 PPM1E LLGL2 SHANK2 CLCN5

8.18e-051911035963f4f2e852bbb4faf070aafb0d368297abacd3b
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

RELN GRIK3 FREM1 CNTNAP2 TANC1

8.18e-051911035de54dab85db70f847de75b3b6d7667a0e13b9bfb
ToppCellCOVID-19-kidney-TAL|COVID-19 / Disease (COVID-19 only), tissue and cell type

OXR1 PPM1E PPP2R3A SHANK2 CLCN5

8.18e-051911035fe55475ce0666ab5122447a813dc2369e24947b8
ToppCell5'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CDHR1 LLGL2 ZNRF3 FZD5 RAB3IP

8.18e-051911035a8d77095ba20b47fc70ba04f80759fbce873253d
ToppCelldroplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PLIN4 CABP1 PPM1E ATP1B2 PALLD

8.18e-05191103560bc1f3efa7bbad5cb7944fe5e049ea79cd1745a
ToppCell10x5'-bone_marrow-Lymphocytic_Invariant-Inducer-like-MAIT|bone_marrow / Manually curated celltypes from each tissue

PDE8A CD40LG IL4I1 IL17RB CCDC107

8.18e-0519110357a28905ad504979497836e87df81d529e675ce78
ToppCellCOVID-19-kidney-Mito-rich_Distal|COVID-19 / Disease (COVID-19 only), tissue and cell type

OXR1 PPM1E PPP2R3A SHANK2 CLCN5

8.18e-0519110350965f621ebcd92ccdeb21cc27022180ce3cfe910
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

GRIK3 FREM1 RAB3IP TANC1 ATP1B2

8.18e-0519110359c0ee270209b02043393416ecc9a81ddedfbb8b6
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

RELN GRIK3 RAB3IP CNTNAP2 TANC1

8.59e-0519310352189da4b727e25e62669d7b9257f06493be21a27
ToppCellSomatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

GRIK3 FREM1 RAB3IP TANC1 ATP1B2

8.59e-0519310358b77625bf3c87d39767fb391d1beaca4ab02342b
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

RELN GRIK3 RAB3IP CNTNAP2 TANC1

8.59e-0519310353ed46f5a7419ec4eddbd0df0d9b5f53aa486198b
ToppCellmoderate-Myeloid-Monocyte-derived_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

DCHS2 SRGAP2 STAT2 MMP13 IL4I1

8.59e-05193103522455801194bd8c73c5c397f5eac4f723429c383
ToppCellInt-URO-Lymphocyte-T_NK-NK|Int-URO / Disease, Lineage and Cell Type

ZNF600 LLGL2 CEP78 ENPP5 PRKCH

8.59e-0519310355c7942f630fc69374df34ee3602ad973b6ced17a
ToppCell10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-innate_lymphocytic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

CENPF DTL LLGL2 CEP78 PRKCH

8.80e-0519410358bfd7c5be518b81b17913139bcb3ebea01f48dd5
ToppCelldroplet-Pancreas-Exocrine-21m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CENPF DTL PTX3 FZD2 PALLD

8.80e-051941035775600880bb77781de48085d8744c1030223de1f
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

OXR1 PPP2R3A LLGL2 SHANK2 ZNRF3

8.80e-0519410357002937e8903e037332a215d00fbc7c7843b33f2
ToppCelldroplet-Pancreas-Exocrine-21m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CENPF DTL PTX3 FZD2 PALLD

8.80e-05194103504ecb609d233a4b12e275c604810937830363e17
ToppCellICU-NoSEP-Lymphocyte-T_NK-NK|ICU-NoSEP / Disease, Lineage and Cell Type

ZNF600 LLGL2 CEP78 ENPP5 PRKCH

8.80e-051941035090edfc884655e5ab38b027c6e1a5aa809ebb19d
ToppCell10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

CENPF DTL LLGL2 CEP78 PRKCH

8.80e-051941035f0707601883b234ed477c7704ca9a88efaefc3fd
ToppCellTracheal-10x3prime_v2-Epithelial-Epi_submucosal-gland-SMG_Duct|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

DCHS2 TCN1 PIWIL4 MAEL IL17RB

9.01e-051951035fdbb4abc0c79a6aeace71bfa5a5c5576ca39d758
ToppCellMid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

CABP1 GABRG2 OXR1 SHANK2 CNTNAP2

9.23e-051961035676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCellControl-Lymphocyte-T_NK-NK_CD56bright|Control / Disease, Lineage and Cell Type

CDHR1 PYROXD2 ZNF600 CEP78 CRBN

9.23e-051961035c0ebef067aa333c7a18c697031b0417b3335b75c
ToppCellSomatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

RELN FREM1 RAB3IP CNTNAP2 ATP1B2

9.23e-0519610357af6c5147ac859353504d19727dbe24f63a29dd4
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

LLGL2 CEP78 CD40LG PRKCH CCDC107

9.23e-05196103560f5deb97f3d6f8422bb5849778205a7022002ae
ToppCell3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

AK9 LGSN SHANK2 DNAH5 DNAH6

9.46e-05197103574a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCell3'-Pediatric_IBD-SmallIntestine-Epithelial-epithelial_progenitor_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CDHR1 LLGL2 ZNRF3 UGT2B17 CLUH

9.46e-051971035c0250509836f1be04f5e54386191d7bb1e1da652
ToppCellTracheal-NucSeq-Epithelial-Epi_airway_ciliated-Deuterosomal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

NAT1 CENPF DTL PPM1E DNAH6

9.69e-051981035f31790442ef142f1c0c49bf3daf2d0efb193d2c9
ToppCellLPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type

AK9 DNAH1 WDR35 DNAH5 DNAH6

9.69e-0519810356d90b541fde357fbb40f8f7d4e8628a48b679718
ToppCellCOVID_non-vent-Lymphocytic-ILC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass

LLGL2 CEP78 ENPP5 PRKCH PALLD

9.92e-051991035df4f7d5be099e3e6054f3b812ccf70251664e4c0
ToppCellCOVID_vent-Lymphocytic-ILC|COVID_vent / Disease condition, Lineage, Cell class and subclass

ZNF600 LLGL2 CEP78 PRKCH PALLD

9.92e-051991035e3ff7fa1b1de1aaf6b46cdf49afa95bad457728a
ToppCellCOVID-19_Moderate-NK|COVID-19_Moderate / disease group, cell group and cell class

ZNF600 LLGL2 CEP78 PRKCH PALLD

9.92e-051991035e0e83ba511957be9ad3413460dcb6b7d7b65dd18
ToppCellCOVID_non-vent-Lymphocytic-ILC-NK_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass

LLGL2 CEP78 ENPP5 PRKCH PALLD

9.92e-051991035ed35d747f11f6ea6a5cb7061057f0a98d9e0db99
ToppCellCOVID_vent-Lymphocytic-ILC-NK_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass

ZNF600 LLGL2 CEP78 PRKCH PALLD

9.92e-0519910355f914962e2572b0c6372465b81b7496fa663d93c
ToppCellBronchial-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

PDE8A DTL PEX5L UGT2B17 IL17RB

9.92e-051991035e1190b1c2d21fed313bb58e24d0e6365de6e6599
ToppCellCOVID-19_Severe-CD8+_T_activated|COVID-19_Severe / disease group, cell group and cell class

LLGL2 CEP78 ENPP5 PRKCH PALLD

9.92e-051991035a16b961996291bd5958c3851b7fdd7b45c53e19b
ToppCellFrontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

DCHS2 RELN TCN1 FREM1

9.99e-051041034b5ca6e589f414e549f4990fe334d4ee54829b298
ToppCellNeuronal-Inhibitory-iB-iB_4(SST)-B3GAT2|Neuronal / cells hierarchy compared to all cells using T-Statistic

RELN GRIK3 FREM1 CNTNAP2 TANC1

1.02e-042001035858421b91f5207b7934b5c219752cb9322a3da31
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

PLIN4 ZNRF3 BSG ENPP5 IL17RB

1.02e-0420010357a8160e6477708f22e48c609bf8f43f3715dcb03
ToppCellNeuronal-Inhibitory-iB-iB_4(SST)-B3GAT2-|Neuronal / cells hierarchy compared to all cells using T-Statistic

RELN GRIK3 FREM1 CNTNAP2 TANC1

1.02e-042001035a7022762c1d8aedb7b3e9605873b1e68b9907b35
ToppCellSepsis-ICU-NoSEP-Lymphocyte-T/NK-CD4+_CTL|ICU-NoSEP / Disease, condition lineage and cell class

LLGL2 CD40LG PRKCH PALLD CCDC107

1.02e-042001035c470520ce77130811fdc2a1d3d796d8836275de1
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Cortical_neuron|GW09 / Sample Type, Dataset, Time_group, and Cell type.

GABRG2 GRIK3 FOXP4 SHANK2 CNTNAP2

1.02e-04200103544bc4d6616fc8d0ad8498e56125939034e8cff01
ToppCellSepsis-ICU-NoSEP-Lymphocyte-T/NK-NK|ICU-NoSEP / Disease, condition lineage and cell class

ZNF600 LLGL2 CEP78 ENPP5 PRKCH

1.02e-0420010356d1e927c4498dc8a6152c211d414f719d9c1f436
ToppCellNeuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-GGH-L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic

RELN CDHR1 VWDE CNTNAP2 ATP1B2

1.02e-04200103548303e499251d6754cfa991dc2d96c5563b2123c
ToppCellSepsis-Int-URO-Lymphocyte-T/NK-NK|Int-URO / Disease, condition lineage and cell class

ZNF600 LLGL2 CEP78 ENPP5 PRKCH

1.02e-0420010353ae0f3dc4f6c9e0315155de80967134b2c1b3364
ToppCellCOVID-19-COVID-19_Severe-Lymphocyte-T/NK-NK_CD56bright|COVID-19_Severe / Disease, condition lineage and cell class

CDHR1 PYROXD2 ZNF600 CEP78 PRKCH

1.02e-04200103512626d046a3ed8db1c9bd603ada5b97ead93e587
ToppCellNeuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-GGH|Neuronal / cells hierarchy compared to all cells using T-Statistic

RELN CDHR1 VWDE CNTNAP2 ATP1B2

1.02e-0420010354802dd6cae84b41746227a5d1aa1c9b858495e36
ToppCellNeuronal-Inhibitory-iB-iB_4(SST)-B3GAT2--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic

RELN GRIK3 FREM1 CNTNAP2 TANC1

1.02e-0420010352131c8e7fa054b79906eaf60536da892438b09cd
ToppCellLA-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper

NAT1 PJA1 MYO18B PALLD

3.04e-0413910349e2a84d5ed7232b70eadbba754d9ca13f2d50fe9
ToppCellPosterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

DCHS2 PEX5L IL4I1 DNAH6

3.48e-04144103408005be9e3367f78ef27e125d9cce5ca53f4bd2d
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c07-AHNAK|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)

PDE8A TOMM70 ZNF600 TANC1

3.57e-041451034c0894c738815ff54790caddb4bccfa1503fd555b
ToppCellCOVID-19_Severe-MAIT|World / disease group, cell group and cell class

GABRG2 CD40LG MAP2K5 CCDC107

3.57e-0414510348d63f97812f63329ef9c940b291dc5a1c4d90690
ToppCellHealthy-B_cell|World / disease group, cell group and cell class

KRI1 ZNF600 CNTNAP2 ENPP5

3.67e-041461034588359d3df6ad7090b7fa6c7f8d29cc1717e7f4f
DiseaseSmall cell carcinoma of lung

GRIK3 NDRG1 CNTNAP2 MYO18B EP300

1.30e-06541035C0149925
DiseaseDent disease

OCRL CLCN5

1.21e-0521032cv:C0878681
DiseaseDent disease (is_implicated_in)

OCRL CLCN5

1.21e-0521032DOID:0050699 (is_implicated_in)
Diseasecholic acid glucuronide measurement

UGT2B15 UGT2B17

3.61e-0531032EFO_0800574
DiseaseX-25937 measurement

UGT2B15 UGT2B17

7.21e-0541032EFO_0800937
DiseaseREM sleep behavior disorder

OCRL SCARB2

1.79e-0461032EFO_0007462
DiseaseX-24574 measurement

UGT2B15 UGT2B17

2.51e-0471032EFO_0800897
DiseasePrimary ciliary dyskinesia

CENPF DNAH1 DNAH5

2.71e-04361033cv:C0008780
DiseaseProstatic Neoplasms

NAT1 CENPF LMTK2 FOXP4 NDRG1 UGT2B15 UGT2B17 ENPP5 MMP13

3.12e-046161039C0033578
DiseaseMalignant neoplasm of prostate

NAT1 CENPF LMTK2 FOXP4 NDRG1 UGT2B15 UGT2B17 ENPP5 MMP13

3.12e-046161039C0376358
Diseasedeoxycholic acid glucuronide measurement

UGT2B15 UGT2B17

3.33e-0481032EFO_0800575
Diseaseautosomal recessive intellectual developmental disorder (implicated_via_orthology)

CNTNAP2 CRBN

3.33e-0481032DOID:0060308 (implicated_via_orthology)
Diseaseautistic disorder (is_implicated_in)

RELN SHANK2 CNTNAP2

4.30e-04421033DOID:12849 (is_implicated_in)
Disease4-androsten-3alpha,17alpha-diol monosulfate (3) measurement

UGT2B15 UGT2B17

5.33e-04101032EFO_0022090
DiseaseDNA repair protein RAD51 homolog 4 measurement

UGT2B15 UGT2B17

6.50e-04111032EFO_0801531
Disease5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement

UGT2B15 UGT2B17

7.78e-04121032EFO_0800291
Diseaseandrostenediol (3alpha, 17alpha) monosulfate (3) measurement

UGT2B15 UGT2B17

9.18e-04131032EFO_0800293
DiseaseX-19141 measurement

UGT2B15 UGT2B17

9.18e-04131032EFO_0800799
Diseasenose morphology measurement

DCHS2 TRMO SRGAP2 TASOR2 CNTNAP2 UGT2B15

1.06e-033291036EFO_0007843
Disease5alpha-androstan-3alpha,17alpha-diol monosulfate measurement

UGT2B15 UGT2B17

1.07e-03141032EFO_0800283
DiseaseSynostotic Posterior Plagiocephaly

FREM1 WDR35

1.40e-03161032C1833340
DiseaseCraniosynostosis, Type 1

FREM1 WDR35

1.40e-03161032C4551902
DiseaseAcrocephaly

FREM1 WDR35

1.40e-03161032C0030044
DiseaseTrigonocephaly

FREM1 WDR35

1.40e-03161032C0265535
DiseaseScaphycephaly

FREM1 WDR35

1.40e-03161032C0265534
DiseaseSynostotic Anterior Plagiocephaly

FREM1 WDR35

1.40e-03161032C2931150
DiseaseMetopic synostosis

FREM1 WDR35

1.40e-03161032C1860819
DiseaseBrachycephaly

FREM1 WDR35

1.59e-03171032C0221356
Diseasetestosterone measurement

SCFD2 DOCK4 DCHS2 POLR1A PDE8A POLR2A FBXO38 TXNDC15 CNTNAP2 UGT2B15 UGT2B17 ATP1B2

1.64e-03127510312EFO_0004908
Disease5alpha-androstan-3alpha,17beta-diol monosulfate (1) measurement

UGT2B15 UGT2B17

1.78e-03181032EFO_0800288
Diseaseetiocholanolone glucuronide measurement

UGT2B15 UGT2B17

1.99e-03191032EFO_0800362
DiseaseCraniosynostosis

FREM1 WDR35

2.20e-03201032C0010278
Diseaseandrosterone glucuronide measurement

UGT2B15 UGT2B17

2.20e-03201032EFO_0800317
Diseaseprostate cancer (is_marker_for)

STAT5A MMP13 MAP2K5 EP300

2.21e-031561034DOID:10283 (is_marker_for)
Diseasegestational age, birth measurement

OXR1 PPP2R3A

2.43e-03211032EFO_0005112, EFO_0006921
DiseaseAlcoholic Intoxication, Chronic

GABRG2 NAT1 GRIK3 CNTNAP2 EP300

2.53e-032681035C0001973
DiseaseX-24947 measurement

UGT2B15 UGT2B17

2.66e-03221032EFO_0800910
Diseasecotinine measurement

CNTNAP2 UGT2B15

2.91e-03231032EFO_0007813
Diseasecongestive heart failure (is_marker_for)

TOMM70 FOXP4 CD40LG

3.00e-03821033DOID:6000 (is_marker_for)
Diseasecongenital diaphragmatic hernia (biomarker_via_orthology)

FREM1 EP300

3.17e-03241032DOID:3827 (biomarker_via_orthology)
Diseaseepiandrosterone sulfate measurement

UGT2B15 UGT2B17

3.44e-03251032EFO_0021120

Protein segments in the cluster

PeptideGeneStartEntry
PFENLNIHCGDAMDL

NAT1

36

P18440
LVAAQANPMEQGHFA

EP300

2351

Q09472
NRFELSMNEHPPQGE

CDHR1

361

Q96JP9
NMLEALPEGLFQHLA

CPN2

131

P22792
INQKDGMVSFHDNPE

COPS3

351

Q9UNS2
FEMQKGDQNPQIAAH

CD40LG

111

P29965
DHPFLKEMQDQGENL

GSDMA

136

Q96QA5
DQQDAAHNMGNHLPL

CRBN

6

Q96SW2
IAGEQMLEDGPHNAN

CCDC70

206

Q6NSX1
GIDQSDFQLLGHPQM

CEP78

551

Q5JTW2
PNMEHVLAVANEEGF

DTL

61

Q9NZJ0
HQTFPLQLENGQAME

AGO4

281

Q9HCK5
NHMDPNQKGFLEVSN

DHTKD1

621

Q96HY7
QQINMNLGGHVDFDD

CABP1

271

Q9NZU7
DQLLNGMAVENGHPV

RC3H2

1091

Q9HBD1
NPNDNDHVEAIFMTL

RAB33B

181

Q9H082
AMANDPLEGFHEVNL

RAB3IP

16

Q96QF0
PFLQMEGHVIQSNGD

QSER1

766

Q2KHR3
QFEEPEMANQALLKH

GRSF1

296

Q12849
NGPRSHESFQEMDLN

FKBP14

136

Q9NWM8
LQEGIMADFHSFINP

MAEL

146

Q96JY0
APGVEFMGLHQENNA

LLGL2

61

Q6P1M3
EDAENLGNFVMFPAN

ATP1B2

206

P14415
LQGQHNFDEDEMDDP

FER1L4

1121

A9Z1Z3
IGAHNIPNANMNEDG

IL17RB

136

Q9NRM6
HFMLPDDDVQGIQSL

MMP13

251

P45452
EELMGHPFIVQFNDG

MAP2K5

411

Q13163
YLEAAHQNGDMIDPD

PEX5L

461

Q8IYB4
HQNGDMIDPDLQTGL

PEX5L

466

Q8IYB4
MDQPELFQAANLGDL

PEX5L

601

Q8IYB4
ADVQFGPMRFHQDQL

PDE8A

66

O60658
FVDLPDLMQHLDNNF

PDE8A

796

O60658
VNDMNPGNLHLFINA

NDRG1

216

Q92597
ENHGIVANDMFDPIR

ENPP5

86

Q9UJA9
HMSNNVLEVPEFNGL

FREM1

136

Q5H8C1
IMPNLLGHTNQEDAG

FZD2

56

Q14332
DDFDPAQHDQLMQKC

KRI1

386

Q8N9T8
LSDNLMHQDNFDPLN

LMTK2

701

Q8IWU2
MHQDNFDPLNVQELS

LMTK2

706

Q8IWU2
DSNGEMSPAELLHFQ

FOXP4

51

Q8IVH2
ADLNSMFLPHENGLS

PPP2R3A

66

Q06190
MGDIPAAVNAFQEAA

NASP

56

P49321
VSNVPNHNEMFDRFE

RELN

1441

P78509
FVSVLDDNDHAPQFM

DCHS2

2756

Q6V1P9
NLVRQEMFPHDPAEA

PPM1E

291

Q8WY54
MQFNAAERETNGVHP

PALLD

601

Q8WX93
MFDPHKNDPLVQENG

OXR1

241

Q8N573
PGEQQFAADALNEME

FBXO38

531

Q6PIJ6
MPNQFNHDTQDEAGL

FZD5

51

Q13467
NDMPEIFGLHDNANI

DNAH1

3941

Q9P2D7
DDPEIFGMHENANLV

DNAH6

3811

Q9C0G6
EQHLNNLMAQLDPLF

CCDC107

121

Q8WV48
EAFQQRMLNEFPHAI

DOCK4

1346

Q8N1I0
ALVPMDFLGNQEDIH

CENPF

1756

P49454
MQLCGPQAQDEHLAA

CHAC1

186

Q9BUX1
HIAQMANQDPDSILF

CLCN5

801

P51795
IDAECQLQLHNFPMD

GABRG2

186

P18507
MAEGDEAARGQQPHQ

ATL2

1

Q8NHH9
HIENLNMEADPGQYR

BSG

286

P35613
EPYNIDVDHRNMANG

CNTNAP2

1096

Q9UHC6
DGPNAQVMNAEEHAF

GRIK3

46

Q13003
FGPEHMGDLQRELNL

POLD1

156

P28340
DFLPQAQDSNHFIME

IKZF4

41

Q9H2S9
PDNIHQEVSFNMLDA

DNAH5

141

Q8TE73
FLNNHDQPFMQELVD

LGSN

231

Q5TDP6
MYVNLDNEIDNGLHP

PTX3

26

P26022
GHSPEDIYQMALNQA

IL4I1

176

Q96RQ9
GDIFHPMNAEEQAQL

PLIN4

1146

Q96Q06
MAEHNPQYLIELNGN

AK9

256

Q5TCS8
NADFDGDEMNAHFPQ

POLR1A

586

O95602
MLQNLDSPFQDQLHQ

STAT2

6

P52630
RPNMICNFLHENEDE

GTF3C6

136

Q969F1
NVIYDDNGLKPDHMQ

PIWIL4

786

Q7Z3Z4
DERFVSAIEGMHPNQ

SCARB2

346

Q14108
HPMTDEQIFQAINAG

TANC1

766

Q9C0D5
NHVPAAAAAEMEGQQ

SCFD2

116

Q8WU76
NAALGFAQMLPRDQH

SPG7

601

Q9UQ90
HQEDLFQTPGMQEEL

OCRL

751

Q01968
NLDVVFMAHPSQENA

PM20D2

181

Q8IYS1
FGAMVNNPHLSDVQF

SLX4

681

Q8IY92
AFMDNEIDGSHLPNL

SHANK2

1806

Q9UPX8
NMYPQNPDHVLDQDG

STAT5A

736

P42229
NPHIGIDMIDNDQGS

ARNTL

576

O00327
QPGLDLNDHVGEQDM

CDYL2

176

Q8N8U2
HAPQVADAILGNQMF

CLTC

591

Q00610
FGEDHPEMALLDNNI

CLUH

1096

O75153
NPENDFHDKNGMQID

VWDE

571

Q8N2E2
IMLFTNEDNPHGNDS

XRCC6

166

P12956
IFNNPEHSLMGLEQF

TRMO

66

Q9BU70
MDFPGHFEQIFQQLN

ZBTB5

1

O15062
LLDAAPVDMAAFQHG

PYROXD2

176

Q8N2H3
FDGDEMNLHLPQSLE

POLR2A

496

P24928
FNNHRPMDPEVIAQD

SRGAP2

931

O75044
HDPMGQDRAAEEANA

TXNDC15

66

Q96J42
FQAEIENMEAHNGTP

TCN1

126

P20061
NMAADIDPQNADVYH

TOMM70

391

O94826
MNQAPVELAHFVGSD

UBQLNL

141

Q8IYU4
FQNRQFAHLMEEPLG

MYO18B

2406

Q8IUG5
MHPLGLCNNNDEEDL

ZNRF3

101

Q9ULT6
HLAFQGQMAAATAEP

TLN2

1896

Q9Y4G6
HKNGPNTENMNLEAF

TASOR2

1241

Q5VWN6
MVGIPLFADQHDNIA

UGT2B15

391

P54855
MQAFGQSFLQPDIHL

XPO6

981

Q96QU8
HENDQNPVLIDTGMY

WDR35

241

Q9P2L0
FQCQEDERNGHEAPM

ZNF600

46

Q6ZNG1
HELMQPGVFMLDGNN

PJA1

481

Q8NG27
MVGIPLFADQHDNIA

UGT2B17

391

O75795
GHLPMINQDEFRNFS

PRKCH

661

P24723